Insitu hybridization auto
CPT 88367 covers automated in situ hybridization (ISH) testing, a laboratory technique that detects specific DNA or RNA sequences in tissue samples using computerized equipment. This test helps identify genetic abnormalities, infections, or cancer markers at the cellular level.
This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.
RVU breakdown
Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High
NCCI bundling edits
Loading bundling edits…
Billing tips
Bill one unit of 88367 per probe set or per slide prepared with automated ISH methodology, not per specimen received
Impact: Incorrect unit billing is the most common error; proper unit calculation can affect revenue by 30-50% when multiple probes are required
Document the specific automated imaging system used (brand and model) and the computerized analysis methodology in the pathology report
Impact: Distinguishes automated (88367) from manual (88365) ISH for audits; prevents $20-30 downcoding to manual methodology
Verify that the automated ISH is not bundled into other molecular pathology codes when billing comprehensive cancer panels
Impact: Prevents double billing; NCCI edits may bundle ISH into larger genomic panels, avoiding compliance violations
For Medicare patients, ensure medical necessity is documented with specific ICD-10 codes linking the ISH test to diagnosis or treatment decisions
Impact: Medicare LCD policies require documented medical necessity; missing documentation causes denials of the full $105.77 payment
When billing 88367 with 88360 (tumor immunofluorescence), append modifier 59 if both procedures are medically necessary and distinct
Impact: Prevents bundling denials; without modifier 59, payers may deny one service entirely, losing $105.77 in revenue
Separate billing for professional and technical components (26/TC modifiers) only when services are actually split between different entities
Impact: Improper modifier use triggers audits; correct split billing ensures accurate reimbursement allocation between hospital and pathologist
Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.
Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.
Help build the field knowledge
MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.